Autoimmune Life Blog

Learn how our biorepositories power life-changing breakthroughs.

Benaroya Research Institute honors and remembers (“Becky”) Benaroya, a beloved member of our community whose generosity, compassion and commitment to improving lives leaves a remarkable impact.

Read recent highlights and learn what’s on the horizon in 2026 from BRI President Jane Buckner, MD.

Learn how research led by Jane Buckner, MD, is bringing regulatory T cell-based therapies closer to clinical trials.

Allyson Byrd, PhD, is an expert in the gut microbiome, the study of the tiny organisms that live inside our digestive system. James Lord, MD, PhD, is a gastroenterologist who has studied inflammatory bowel diseases (IBD) like Crohn’s disease and ulcerative colitis for more than 20 years.

Learn how CRISPR-Cas9-based genome engineering using adeno-associated virus (AAV) vectors is helping BRI scientists make breakthroughs to study human T cells and explore new treatments for type 1 diabetes, as well as  develop preclinical models to study T cells and B cell

At first, Cate Speake, PhD, and her team weren’t sure that a mysterious phenomenon called autoantibody reversion was actually happening. But no matter how they sliced the data, they saw the same pattern. Learn how autoantibody reversion could unlock new clues to preventing type 1 diabetes.

Learn how lab-grown human beta cells are helping Eddie James, PhD, and other BRI researchers answer important questions in type 1 diabetes. 

Find out about new advances in autoimmune disease screening from a team led by Cate Speake, PhD.

Read exciting updates and learn what’s on the horizon for 2025 from BRI President Jane Buckner, MD.